Regulatory aspects and accreditation of the clinical use of hematopoietic progenitor cells in Europe

Journal of Biological Regulators and Homeostatic Agents

Volumn 15, Issue 1, 2001, Pages 79-80

  Kvalheim, G ^a   Urbano Ispizua, A ^a   Gratwohl, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ACCREDITATION; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL LABORATORY; CLINICAL PROTOCOL; CONTROLLED STUDY; EUROPE; GENETIC MANIPULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LAW; NORTH AMERICA; PRACTICE GUIDELINE; STANDARD; UMBILICAL CORD BLOOD;

EID: 0035019447     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Blood and marrow transplantation activity in Europe 1997
2. The biology and clinical uses of blood stem cells
3. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers
4. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor
5. - Cell enumeration
6. + cell enumeration in peripheral blood: Dual-platform ISHAGE protocol versus single-platform, versus microvolume fluorimetry
7. - Expressing cells
8. FAHCT-JACIE workshop on accreditation for blood and marrow progenitor cell processing, collection and transplantation
9. NETCORD: A cord blood allocation network